E-LIB Suche - Ergebnisse für: Vickers, Molly A

1

Monovalent SARS-CoV-2 mRNA Vaccine Does not Boost Omicron-S..:

Sariol, Alan ; Vickers, Molly A ; Christensen, Shannon M...
The Journal of Infectious Diseases. 229 (2023) 4 - p. 1059-1067 , 2023

Link: https://doi.org/10.1093/..

2

Waning of Maternal Antibodies against Measles Suggests a La..:

Khampanisong, Phonepaseuth ; Pauly, Maude ; Nouanthong, Phonethipsavanh...
Pathogens. 10 (2021) 10 - p. 1316 , 2021

Link: https://doi.org/10.3390/..

3

Exponential increase in neutralizing and spike specific ant..:

Vickers, Molly A. ; Sariol, Alan ; Leon, Judith...
Transfusion. 61 (2021) 7 - p. 2099-2106 , 2021

Link: https://doi.org/10.1111/..

4

The development of Nanosota-1 as anti-SARS-CoV-2 nanobody d..:

Ye, Gang ; Gallant, Joseph ; Zheng, Jian...
eLife. 10 (2021) - p. , 2021

Link: https://doi.org/10.7554/..

5

Monitoring Anti-tuberculosis Treatment Response Using Analy..:

Vickers, Molly A. ; Darboe, Fatoumatta ; Muefong, Caleb N....
Frontiers in Immunology. 11 (2020) - p. , 2020

Link: https://doi.org/10.3389/..

6

Waning of Maternal Antibodies against Measles Suggests a La..:

Khampanisong, Phonepaseuth ; Pauly, Maude ; Nouanthong, Phonethipsavanh...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538652/. , 2021

Link: http://www.ncbi.nlm.nih...

7

Waning of maternal antibodies against measles suggests a la..:

Khampanisong, Phonepaseuth ; Pauly, Maude ; Nouanthong, Phonethipsavanh...
https://westminsterresearch.westminster.ac.uk/download/30168b4c7e18333f53ef28f5d8c33d336761fc40b48fbd2b0ad7d62e3ca4642a/781655/pathogens-10-01316-v3.pdf. , 2021

Link: https://westminsterresea..

8

Monitoring Anti-tuberculosis Treatment Response Using Analy..:

Vickers, Molly A ; Darboe, Fatoumatta ; Muefong, Caleb N...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931252/. , 2020

Link: http://www.ncbi.nlm.nih...

9

Monitoring Anti-tuberculosis Treatment Response Using Analy..:

Vickers, Molly A ; Darboe, Fatoumatta ; Muefong, Caleb N...
https://researchonline.lshtm.ac.uk/id/eprint/4659089/1/fimmu-11-572620.pdf. , 2020

Link: https://researchonline.l..

10

The Development of a Novel Nanobody Therapeutic for SARS-Co..:

Ye, Gang ; Gallant, Joseph P ; Massey, Christopher...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685322/. , 2020

Link: http://www.ncbi.nlm.nih...

11

Table_1_Monitoring Anti-tuberculosis Treatment Response Usi..:

Molly A. Vickers ; Fatoumatta Darboe ; Caleb N. Muefong...
doi:10.3389/fimmu.2020.572620.s005. , 2021

Link: https://doi.org/10.3389/..

12

Image_2_Monitoring Anti-tuberculosis Treatment Response Usi..:

Molly A. Vickers ; Fatoumatta Darboe ; Caleb N. Muefong...
doi:10.3389/fimmu.2020.572620.s007. , 2021

Link: https://doi.org/10.3389/..

13

The development of Nanosota-1 as anti-SARS-CoV-2 nanobody d..:

Gang Ye ; Joseph Gallant ; Jian Zheng...
https://elifesciences.org/articles/64815. , 2021

Link: https://doi.org/10.7554/..

14

Waning of Maternal Antibodies against Measles Suggests a La..:

Phonepaseuth Khampanisong ; Maude Pauly ; Phonethipsavanh Nouanthong...
Viral Pathogens. , 2021

Link: https://doi.org/10.3390/..

15

Image_3_Monitoring Anti-tuberculosis Treatment Response Usi..:

Molly A. Vickers ; Fatoumatta Darboe ; Caleb N. Muefong...
doi:10.3389/fimmu.2020.572620.s008. , 2021

Link: https://doi.org/10.3389/..